Hap Trading, LLC Bei Gene, Ltd. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $1.91 Million - $2.89 Million	-10,100 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$123.9 - $195.41 $1.25 Million - $1.97 Million	10,100 New	10,100 $25,000
Q1 2020 May 08, 2020	SELL	$121.84 - $173.19 $1.5 Million - $2.13 Million	-12,300 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$115.78 - $208.34 $1.42 Million - $2.56 Million	12,300 New	12,300 $145,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.